
The scheme supports the development of treatments targeting unmet medical needs in the EU

This type of cancer is the most common one diagnosed in teenagers

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio

Even with countermeasures in place, European auditors warn that the risks remain elevated

On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in England. But what do these...

What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care (DHSC)? What do these changes mean for your...

Discover how health economics can support successful Medical Device launch, proposition development, and market access. Join us live at 1:30pm (GMT) on Wednesday 19th March for an insightful journey into...

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has selected London-based healthcare specialist EatMoreFruit to raise awareness and engagement around its ‘EU Lab Day’; an event co-ordinating 42...

We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...

The new proposal will be finalised after the EU elections take place in June 2024

The deal is aimed at increasing Indegene’s clinical and regulatory writing expertise for global market authorisation applications